Impact of Tai Chi in Cervical Myelopathy
Launched by WEST VIRGINIA UNIVERSITY · Mar 12, 2025
Trial Information
Current as of April 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of Tai Chi on people with a condition called cervical myelopathy, which affects the spine and can lead to balance and walking problems. The researchers want to find out if participating in a Tai Chi program can help improve balance and walking abilities compared to those who receive standard care.
To take part in this study, participants must be 18 years or older and have a diagnosis of cervical myelopathy, with plans for surgery. They should also be able to attend and participate in Tai Chi classes. However, individuals who are wheelchair-bound or have other conditions that cause balance issues may not be eligible. The trial is not currently recruiting participants, but once it begins, those who qualify can expect to engage in Tai Chi classes and help contribute to understanding how this gentle exercise might benefit their condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Cervical Myelopathy with planned surgery
- • 18 years of age or older
- • Able to participate in intervention (attend and participate in classes)
- Exclusion Criteria:
- • Wheelchair bound at initial visit
- • Other verified potential cause of gait instability/balance problems
- • Unable to participate in intervention (unable to attend/participate in classes)
About West Virginia University
West Virginia University (WVU) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a strong commitment to improving patient outcomes, WVU harnesses its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies across a wide range of medical fields. The university collaborates with healthcare providers, industry partners, and regulatory bodies to ensure the highest standards of ethics and scientific integrity in its research endeavors. WVU strives to translate scientific discoveries into practical applications, ultimately enhancing the quality of care for diverse populations in West Virginia and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Scott Daffner, MD
Principal Investigator
West Virginia University School of Medicine, Department of Orthopaedics
Andrya Durr, PhD
Study Director
West Virginia University School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported